Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group.
Guilhot F, Chastang C, Michallet M, Guerci A, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Cheron N, Nicolini F, Abgrall JF, Tanzer J. Guilhot F, et al. Among authors: abgrall jf. N Engl J Med. 1997 Jul 24;337(4):223-9. doi: 10.1056/NEJM199707243370402. N Engl J Med. 1997. PMID: 9227927 Free article. Clinical Trial.
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase.
Maloisel F, Guerci A, Guyotat D, Ifrah N, Michallet M, Reiffers J, Tertain G, Blanc M, Bauduer F, Brière J, Abgrall JF, Pegourie-Bandelier B, Solary E, Cambier N, Coso D, Vilque JP, Delain M, Harousseau JL, Rousselot P, Belhadj K, Morice P, Attal J, Chabin M, Chastang C, Guilhot J, Guilhot F; France Intergroupe des Leucémies Myéloïdes Chroniques. Maloisel F, et al. Among authors: abgrall jf. Leukemia. 2002 Apr;16(4):573-80. doi: 10.1038/sj.leu.2402433. Leukemia. 2002. PMID: 11960335 Clinical Trial.
A multicentric randomised study of alpha 2b interferon (IFN) and hydroxyurea (HU) with or without cytosine-arabinoside (Ara-c) in previously untreated patients with Ph+ chronic myelocytic leukemia (CML): preliminary cytogenetic results.
Guilhot F, Abgrall JF, Harousseau JL, Bauters F, Brice P, Dine G, Tilly H, Ifrah N, Cassasus P, Rochant H, et al. Guilhot F, et al. Among authors: abgrall jf. Leuk Lymphoma. 1993;11 Suppl 1:181-3. doi: 10.3109/10428199309047883. Leuk Lymphoma. 1993. PMID: 8251893 Clinical Trial.
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group.
Guilhot F, Guerci A, Fiere D, Harousseau JL, Maloisel F, Bouabdallah R, Guyotat D, Rochant H, Najman A, Nicolini F, Colombat P, Abgrall JF, Ifrah N, Brière J, Bauters F, Navarro M, Morice P, Bordessoule D, Vilque JP, Desablens B, Tertian G, Blanc M, Chastang C, Tanzer J. Guilhot F, et al. Among authors: abgrall jf. Bone Marrow Transplant. 1996 May;17 Suppl 3:S29-31. Bone Marrow Transplant. 1996. PMID: 8769697 Clinical Trial. No abstract available.
Comparison of autologous bone marrow transplantation and intensive chemotherapy as postremission therapy in adult acute myeloid leukemia. The Groupe Ouest Est Leucémies Aiguës Myéloblastiques (GOELAM).
Harousseau JL, Cahn JY, Pignon B, Witz F, Milpied N, Delain M, Lioure B, Lamy T, Desablens B, Guilhot F, Caillot D, Abgrall JF, Francois S, Briere J, Guyotat D, Casassus P, Audhuy B, Tellier Z, Hurteloup P, Herve P. Harousseau JL, et al. Among authors: abgrall jf. Blood. 1997 Oct 15;90(8):2978-86. Blood. 1997. PMID: 9376578 Free article. Clinical Trial.
Granulocyte colony-stimulating factor after intensive consolidation chemotherapy in acute myeloid leukemia: results of a randomized trial of the Groupe Ouest-Est Leucémies Aigues Myeloblastiques.
Harousseau JL, Witz B, Lioure B, Hunault-Berger M, Desablens B, Delain M, Guilhot F, Le Prise PY, Abgrall JF, Deconinck E, Guyotat D, Vilque JP, Casassus P, Tournilhac O, Audhuy B, Solary E. Harousseau JL, et al. Among authors: abgrall jf. J Clin Oncol. 2000 Feb;18(4):780-7. doi: 10.1200/JCO.2000.18.4.780. J Clin Oncol. 2000. PMID: 10673519 Clinical Trial.
Front-line high-dose therapy with autologous stem cell transplantation for high risk Hodgkin's disease: comparison with combined-modality therapy.
Vigouroux S, Milpied N, Andrieu JM, Colonna P, Ifrah N, Colombat P, Desablens B, Abgrall JF, Casassus P, Guilhot F, Briere J, Le Mevel A, Moreau P, Mechinaud F, Mahe B, Morineau N, Vigier M, Rapp MJ, Harousseau JL. Vigouroux S, et al. Among authors: abgrall jf. Bone Marrow Transplant. 2002 May;29(10):833-42. doi: 10.1038/sj.bmt.1703547. Bone Marrow Transplant. 2002. PMID: 12058233
127 results